Natasha K Martin
Natasha K Martin
NIHR Postdoctoral Fellow, University of Bristol and LSHTM
Подтвержден адрес электронной почты в домене bristol.ac.uk
НазваниеПроцитированоГод
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
JD Stanaway, AD Flaxman, M Naghavi, C Fitzmaurice, T Vos, I Abubakar, ...
The Lancet 388 (10049), 1081-1088, 2016
6302016
HCV treatment for prevention among people who inject drugs: modelling treatment scale-up in the age of direct-acting antivirals
N Martin, P Vickerman, J Grebely, M Hellard, S Hutchinson, V Lima, ...
Hepatology, 2013
4192013
Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale‐up in the age of direct‐acting antivirals
NK Martin, P Vickerman, J Grebely, M Hellard, SJ Hutchinson, VD Lima, ...
Hepatology 58 (5), 1598-1609, 2013
4182013
On the foundations of cancer modelling: selected topics, speculations, and perspectives
N Bellomo, NK Li, PK Maini
Mathematical Models and Methods in Applied Sciences 18 (04), 593-646, 2008
3632008
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol …
R Williams, R Aspinall, M Bellis, G Camps-Walsh, M Cramp, A Dhawan, ...
The Lancet 384 (9958), 1953-1997, 2014
3312014
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis
GJ MacArthur, S Minozzi, N Martin, P Vickerman, S Deren, J Bruneau, ...
British Medical Journal Publishing Group 345, e5945, 2012
2892012
Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility
NK Martin, P Vickerman, GR Foster, SJ Hutchinson, DJ Goldberg, ...
Journal of hepatology 54 (6), 1137-1144, 2011
2502011
Cost‐effectiveness of hepatitis C virus antiviral treatment for injection drug user populations
NK Martin, P Vickerman, A Miners, GR Foster, SJ Hutchinson, ...
Hepatology 55 (1), 49-57, 2012
2382012
Public health and international drug policy
J Csete, A Kamarulzaman, M Kazatchkine, F Altice, M Balicki, J Buxton, ...
The Lancet 387 (10026), 1427-1480, 2016
2132016
Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate …
NK Martin, M Hickman, SJ Hutchinson
CLINICAL INFECTIOUS DISEASES 58 (8), 2014
213*2014
Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate …
NK Martin, M Hickman, SJ Hutchinson, DJ Goldberg, P Vickerman
Clinical Infectious Diseases 57 (suppl 2), S39-S45, 2013
2132013
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical …
JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ...
The Lancet Global Health 2 (1), e23-e34, 2014
1602014
Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM
TCS Martin, NK Martin, M Hickman, P Vickerman, EE Page, R Everett, ...
AIDS 27 (16), 2551-2557, 2013
1462013
Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings
P Vickerman, N Martin, K Turner, M Hickman
Addiction 107 (11), 1984-1995, 2012
1442012
Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
NK Martin, P Vickerman, GJ Dore, J Grebely, A Miners, J Cairns, ...
Journal of hepatology, 2016
1272016
Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review
JPT Higgins, K Soares-Weiser, JA López-López, A Kakourou, K Chaplin, ...
bmj 355, i5170, 2016
1232016
A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction
H Moore, NK Li
Journal of theoretical biology 227 (4), 513-523, 2004
1182004
HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact
NK Martin, GR Foster, J Vilar, S Ryder, M E Cramp, F Gordon, JF Dillon, ...
Journal of viral hepatitis 22 (4), 399-408, 2015
952015
Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and …
NK Martin, A Thornton, M Hickman, C Sabin, M Nelson, GS Cooke, ...
Clinical Infectious Diseases 62 (9), 1072-1080, 2016
932016
The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia
FL Altice, L Azbel, J Stone, E Brooks-Pollock, P Smyrnov, S Dvoriak, ...
The Lancet 388 (10050), 1228-1248, 2016
922016
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20